What Patients Should Not Do After GLP-1 Weight Loss Patients should not treat GLP-1 success as permission to stop paying attention to metabolic health
Lekounoungou, F.L
Glutathione assists the body as it processes waste and metabolic byproducts
As depicted in Table 4, exenatide exhibited the broadest spectrum, with a total of 8 potential signals indicating GLP-1 RA-induced AP, ranging from pancreatic abscess (ROR 4.20, 95% CI 1.0317.03) to pancreatic phlegmon (ROR 84.53, 95% CI 21.86326.90)
Recently, a new DON prodrug JHU395, has been developed to treat medulloblastoma (Pham et al., 2021)
While extensive epidemiological studies have consistently indicated a significant neuroprotective effect, the most conclusive clinical trials in Alzheimers disease have not corroborated this benefit, presenting a critical conundrum for the field